(Q45864674)

17 December 2017

title

Dual Therapeutic Effects of Interferon-α Gene Therapy in a Rat Hepatocellular Carcinoma Model With Liver Cirrhosis (English)

1 reference

17 December 2017

main subject

gene therapy

0 references

liver cirrhosis

0 references

hepatocellular carcinoma

1 reference

Kai-Wen Huang

1

1 reference

17 December 2017

Yung-Chi Huang

2

1 reference

17 December 2017

Kuo-Feng Tai

3

1 reference

17 December 2017

Bo-Hua Chen

4

1 reference

17 December 2017

Po-Huang Lee

5

1 reference

17 December 2017

Lih-Hwa Hwang

6

1 reference

17 December 2017

language of work or name

1 reference

1 October 2008

1 reference

17 December 2017

published in

Molecular Therapy

1 reference

17 December 2017

volume

16

1 reference

17 December 2017

issue

10

1 reference

17 December 2017

page(s)

1681-1687

1 reference

17 December 2017

Hepatocellular carcinoma development in cirrhosis

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Role of NK and T cells in IL-12-induced anti-tumor response against hepatic colon carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

The immunization site of cytokine-secreting tumor cell vaccines influences the trafficking of tumor-specific T lymphocytes and antitumor efficacy against regional tumors

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Liver Carcinogenesis by Diethylnitrosamine in the Rat

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Effect of nodularin on the expression of glutathione S-transferase placental form and proliferating cell nuclear antigen in N-nitrosodiethylamine initiated hepatocarcinogenesis in the male Fischer 344 rat.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis, and methylation of p16(INK4A) exon 1 in hepatocellular

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Hepatitis B virus promotes hepatocarcinogenesis in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Adenosine reverses a preestablished CCl4-induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Morphological and biochemical effects of a low ethanol dose on rat liver regeneration: role of route and timing of administration

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Reliable indices for the determination of viability of grafted liver immediately after orthotopic transplantation. Bile flow rate and cellular adenosine triphosphate level

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Local interferon-alpha gene therapy elicits systemic immunity in a syngeneic pancreatic cancer model in hamster

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Interferon-alpha gene therapy by lentiviral vectors contrasts ovarian cancer growth through angiogenesis inhibition

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Adenovirus-mediated gene transfer of interferon α improves dimethylnitrosamine-induced liver cirrhosis in rat model

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Anti-TGF-beta strategies for the treatment of chronic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.160

7 January 2021

Identifiers

DOI

10.1038/MT.2008.160

1 reference

17 December 2017

1 reference

17 December 2017